Financial Health Check: Examining Biohaven Ltd (BHVN)’s Key Ratios

Kiel Thompson

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

Biohaven Ltd (NYSE: BHVN) closed the day trading at $8.26 down -3.17% from the previous closing price of $8.53. In other words, the price has decreased by -$3.17 from its previous closing price. On the day, 6.35 million shares were traded. BHVN stock price reached its highest trading level at $8.5 during the session, while it also had its lowest trading level at $7.6344.

Ratios:

For a better understanding of BHVN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.82 and its Current Ratio is at 3.82. In the meantime, Its Debt-to-Equity ratio is 2.17 whereas as Long-Term Debt/Eq ratio is at 2.13.

On November 05, 2025, BofA Securities Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $10.

On September 17, 2025, Citigroup started tracking the stock assigning a Buy rating and target price of $28.Citigroup initiated its Buy rating on September 17, 2025, with a $28 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 04 ’25 when CHILDS JOHN W bought 32,700 shares for $30.47 per share. The transaction valued at 996,238 led to the insider holds 2,320,571 shares of the business.

CHILDS JOHN W bought 29,000 shares of BHVN for $1,042,393 on Dec 30 ’24. The Director now owns 2,368,741 shares after completing the transaction at $35.94 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHVN now has a Market Capitalization of 873833664 and an Enterprise Value of 503323520.

Stock Price History:

The Beta on a monthly basis for BHVN is 3.74, which has changed by -0.8424566 over the last 52 weeks, in comparison to a change of 0.12121439 over the same period for the S&P500. Over the past 52 weeks, BHVN has reached a high of $54.68, while it has fallen to a 52-week low of $7.80. The 50-Day Moving Average of the stock is -45.40%, while the 200-Day Moving Average is calculated to be -59.23%.

Shares Statistics:

Over the past 3-months, BHVN traded about 2.90M shares per day on average, while over the past 10 days, BHVN traded about 6712540 shares per day. A total of 105.78M shares are outstanding, with a floating share count of 92.38M. Insiders hold about 12.68% of the company’s shares, while institutions hold 75.66% stake in the company. Shares short for BHVN as of 1760486400 were 10304537 with a Short Ratio of 3.56, compared to 1757894400 on 13187804. Therefore, it implies a Short% of Shares Outstanding of 10304537 and a Short% of Float of 10.95.

Earnings Estimates

Investors are eagerly awaiting the insights provided by 6.0 analysts currently analyzing and rating the stock of Biohaven Ltd (BHVN).The consensus estimate for the next quarter is -$1.49, with high estimates of -$1.15 and low estimates of -$1.81.

Analysts are recommending an EPS of between -$5.87 and -$6.87 for the fiscal current year, implying an average EPS of -$6.45. EPS for the following year is -$5.18, with 6.0 analysts recommending between -$2.76 and -$6.37.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.